Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenic thinking and neuroleptic dosage.

A E Puente, C Andersson

    Journal of Clinical Psychology
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    This study found no significant differences in cognitive or self-conscious measures between acute and chronic schizophrenia patients. Neuroleptic drug dosage also did not correlate with thinking abilities in any patient group.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A scoping review of sustainable strategies adopted in nuclear medicine.

    Radiography (London, England : 1995)·2025
    Same author

    A scoping review of person-centred care strategies used in diagnostic Nuclear Medicine.

    Radiography (London, England : 1995)·2024
    Same author

    Two centuries of southwest Iceland annually-resolved marine temperature reconstructed from <i>Arctica islandica</i> shells.

    Estuarine, coastal and shelf science·2023
    Same author

    Concordance between COVID-19 mortality statistics derived from clinical audit and death certificates in Östergötland county, Sweden.

    Public health·2023
    Same author

    Prognostic factors for tibiofemoral and patellofemoral osteoarthritis 32-37 years after anterior cruciate ligament injury managed with early surgical repair or rehabilitation alone.

    Osteoarthritis and cartilage·2021
    Same author

    Cultural accommodations for cutoff scores of embedded performance validity tests in a Spanish college population.

    Applied neuropsychology. Adult·2020
    Same journal

    Profiles of Early Life Stress and Their Interaction With Proximal Stress in Early Adulthood: A Person-Centered Approach.

    Journal of clinical psychology·2026
    Same journal

    Single Versus Multiple Intimate Partner Violence Relationships: Current Severity of Psychological Distress Among Romantic Partners.

    Journal of clinical psychology·2026
    Same journal

    Psychological Distress Profiles in Women With Recurrent Pregnancy Loss During Subsequent Early Pregnancy and Their Association With Sleep Characteristics: A Latent Profile Analysis.

    Journal of clinical psychology·2026
    Same journal

    Personality Traits in Borderline Personality Disorder: A Cluster Analysis Based on the Millon Test Scores.

    Journal of clinical psychology·2026
    Same journal

    Exploring Reasoning Biases Associated With Psychosis in Borderline Personality Disorder Using Self-Report and Objective Measures.

    Journal of clinical psychology·2026
    Same journal

    Maladaptive Perfectionism and Adolescent Nonsuicidal Self-Injury: A Longitudinal Moderated Mediation Model of Hopelessness and Self-Concept Clarity.

    Journal of clinical psychology·2026
    See all related articles

    Area of Science:

    • Psychiatry and Psychology
    • Neuroscience
    • Clinical Research

    Background:

    • Schizophrenia is a complex mental disorder characterized by cognitive deficits and altered self-consciousness.
    • The impact of illness chronicity and neuroleptic medication on cognitive function in schizophrenia remains an area of active investigation.

    Purpose of the Study:

    • To investigate the relationship between schizophrenia chronicity, neuroleptic dosage, and specific cognitive and self-conscious measures.
    • To determine if differences exist in cognitive function and self-consciousness between acute and chronic schizophrenia patients.
    • To explore the correlation between neuroleptic drug dosage and cognitive performance in individuals with schizophrenia.

    Main Methods:

    • A study involving 60 participants diagnosed with schizophrenia, categorized into three groups based on chronicity and medication.

    Related Experiment Videos

  • Administration of standardized psychological assessments: Whitaker Index of Schizophrenic Thinking, Mini-Mental State Examination, and Self-Conscious Scale.
  • Statistical analysis to compare dependent measures across different patient groups (chronic vs. acute, discharged vs. not discharged) and by neuroleptic dose levels.

    • Main Results:

    • No significant differences were found between chronic and acute schizophrenia groups on the assessed cognitive and self-conscious measures.
    • Discharge status of acute patients did not correlate with significant variations in the measured outcomes.
    • Neuroleptic dosage levels and specific thinking abilities in schizophrenia showed no significant association across all participant groups.

    Conclusions:

    • Illness duration (acute vs. chronic) does not appear to significantly alter cognitive function or self-consciousness in schizophrenia.
    • Neuroleptic medication dosage does not demonstrate a direct relationship with the observed thinking patterns or self-conscious states in this cohort.
    • Further research is warranted to elucidate the complex interplay of factors influencing cognitive and self-conscious dimensions in schizophrenia.